Last reviewed · How we verify
NCT06053047: MASTER
Remote Monitoring of the Diabetic Foot to Prevent Re-Ulceration
NA trial testing Bluedrop Monitoring Service (BMS) in Diabetic Foot in 26 participants. Terminated before completion.
18 September 2024
Quick facts
| Lead sponsor | Bluedrop Medical Limited |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 26 |
| Start date | 22 January 2024 |
| Primary completion | 18 September 2024 |
| Estimated completion | 18 September 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Bluedrop Monitoring Service (BMS)
Conditions studied
- Diabetic Foot — all drugs for Diabetic Foot →
Sponsor
Bluedrop Medical Limited
Who can join
18 and older, any sex, with Diabetic Foot. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to understand the effects of the Bluedrop Monitoring System (BMS) on the development of diabetic foot ulcers. All Participants in this study will continue with their normal foot care and complete surveys with questions about their foot health every three months. Participants selected to receive the Bluedrop Monitoring System (BMS) will place it in their home and stand on it once a day for 12 months. Participants will also need to answer questions about their general foot health and, if using the system, their experience using the device and monitoring service.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06053047
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetic Foot
Currently open trials in the same condition.
- NCT06487780 — Evaluating a Lifestyle Intervention to Prevent Recurrence of Diabetic Foot Ulcers · NA · recruiting
- NCT06674980 — Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DF · NA · recruiting
- NCT06760416 — Online Diabetic Foot Support Program- Care Kit · NA · active not recruiting
- NCT06552910 — Analyzing Anesthetic Techniques in Diabetic Foot Amputation · recruiting
- NCT06526936 — The Effect of Foot Care Training Given to Diabetic Hemodialysis Patients on Foot Care Behavior · NA · recruiting
Other Bluedrop Medical Limited trials
Trials by the same sponsor.
- NCT05039645 — Use of Remote Thermovisual Monitoring in Patients With a Previous Diabetic Foot Ulcer · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06053047 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bluedrop Medical Limited
- Last refreshed: 17 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06053047.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing